Sign up to save your podcasts
Or
Share Salmon talks acquisitions, Blackstone, the FDA, and why Medtronic is in diabetes for the long haul
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Salmon talks acquisitions, Blackstone, the FDA, and why Medtronic is in diabetes for the long haul
Sean Salmon, Executive Vice President and President, Diabetes Operating Unit, says Medtronic’s diabetes unit is reinvigorated by acquisitions, new internally developed products and a partnership with a private equity giant. In this MedtronicTalks podcast episode, Salmon explains why the diabetes community is excited about Medtronic’s pipeline and what the company is doing to meet those higher expectations.
View all episodes
By Tom Salemi
4.6
3030 ratings
Sean Salmon, Executive Vice President and President, Diabetes Operating Unit, says Medtronic’s diabetes unit is reinvigorated by acquisitions, new internally developed products and a partnership with a private equity giant. In this MedtronicTalks podcast episode, Salmon explains why the diabetes community is excited about Medtronic’s pipeline and what the company is doing to meet those higher expectations.